73 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
prices, lower reimbursement rates and smaller populations for whom payers will reimburse; changes under the 340B Drug Pricing Program; the company’s
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
populations for whom payers will reimburse; changes under the 340B Drug Pricing Program; our ability to obtain and maintain regulatory approval
424B2
i2vzzmnvz ex9x
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
eaccpj76o6wy8 7eurin
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
424B5
nlfzylmb6 q9a6c
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
nfjvejh36vn0x yun8
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
imhizhk6sse9ulil
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
vb5ihqxq7fw8n
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
s18u89
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
EX-99.1
2qxhcde4bqnirtjmmo30
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
mya1belb
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
j2br6st2
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.2
j3h2den3k2 uo7njmt
3 Mar 22
Upsizing and Early Settlement of Tender Offers
4:16pm
8-K
EX-99.1
78da z2pht
3 Mar 22
Upsizing and Early Settlement of Tender Offers
4:16pm